GLP-1glp-1spine surgerytype 2 diabetespearldiver

GLP-1 use before cervical spine surgery linked to fewer revisions

In a PearlDiver analysis of diabetic patients on metformin, GLP-1 users had 0.33 odds of 90-day revision surgery versus matched controls.

By Maren Holt · Senior Reporter, GLP-1

Oct 20 20:00 ETSource: The spine journal : official journal of the North American Spine Society

The wire

01Retrospective propensity-matched analysis of patients with type 2 diabetes undergoing posterior cervical spine surgery from 2010 to 2023 found lower odds of pneumonitis (OR 0.57), 90-day surgical site infection (OR 0.72) and readmission (OR 0.82) among GLP-1 users.
02At two years GLP-1 users had lower odds of revision surgery (OR 0.31) and nutritional deficiency (OR 0.62), with no significant differences versus patients who had prior bariatric surgery.
03This is claims-database work with residual confounding risk; it shows association, not that preoperative GLP-1 therapy causes the better outcomes.

From the source

Outcomes after Posterior Cervical Spine Surgery: A Matched Cohort Analysis and Comparison of GLP-1 Receptor Agonist Use and Bariatric Surgery in Patients with Type 2 Diabetes
The spine journal : official journal of the North American Spine Society · 2026 Oct 21 · Rivera N, Bradley T, Crowell KA et al.

Read at pubmed.ncbi.nlm.nih.gov

Source URL https://pubmed.ncbi.nlm.nih.gov/42906643/